Recombinant human interleukin 5 is a selective activator of human eosinophil function

Human rIL-5 was found to selectively stimulate morphological changes and the function of human eosinophils. This molecule is thus a prime candidate for the selective eosinophilia and eosinophil activation seen in disease.

[1]  T. Kinashi,et al.  Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. , 1986, Nucleic acids research.

[2]  J. Gamble,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. , 1986, The Journal of clinical investigation.

[3]  M. Vadas,et al.  Murine eosinophil differentiation factor. An eosinophil-specific colony- stimulating factor with activity for human cells , 1986, The Journal of experimental medicine.

[4]  J. David,et al.  Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Oresajo,et al.  The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils , 1985, The Journal of cell biology.

[6]  M. Strath,et al.  Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures , 1985, The Journal of experimental medicine.

[7]  R. Tsuchiya,et al.  Large cell carcinoma of the lung associated with marked eosinophilia. A case report , 1984, Cancer.

[8]  R. Snyderman,et al.  Rapid changes in light scattering from human polymorphonuclear leukocytes exposed to chemoattractants. Discrete responses correlated with chemotactic and secretory functions. , 1984, The Journal of clinical investigation.

[9]  M. Vadas,et al.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. , 1983, Journal of immunology.

[10]  C. McCall,et al.  Comparison of human eosinophils from normals and patients with eosinophilia. , 1980, The Journal of clinical investigation.

[11]  M. Vadas,et al.  Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. , 1980, The New England journal of medicine.

[12]  D. Catovsky,et al.  The Association of Eosinophilia with Lymphoblastic Leukaemia or Lymphoma: a Study of Seven Patients , 1980, British journal of haematology.

[13]  M. Vadas,et al.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. , 1979, Journal of immunology.

[14]  Angel F. Lopez,et al.  Eosinophils and not lymphoid K cells kill Trypanosoma cruzi epimastigotes , 1977, Nature.

[15]  P. Tai,et al.  Studies on blood eosinophils. I. Patients with a transient eosinophilia. , 1976, Clinical and experimental immunology.